HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana Cláudia Camargo Miranda Selected Research

Pentetic Acid (DTPA)

1/2021Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana Cláudia Camargo Miranda Research Topics

Disease

3Neoplasms (Cancer)
01/2024 - 01/2021
2Prostatic Neoplasms (Prostate Cancer)
01/2023 - 02/2020
1Breast Neoplasms (Breast Cancer)
01/2024
1Brain Injuries (Brain Injury)
06/2018

Drug/Important Bio-Agent (IBA)

2RadiopharmaceuticalsIBA
01/2024 - 01/2023
2LigandsIBA
01/2023 - 02/2020
2AntigensIBA
01/2023 - 02/2020
1Peptide FragmentsIBA
01/2024
1tyrosyl-isoleucyl-glycyl-seryl-arginineIBA
01/2024
1Peptides (Polypeptides)IBA
01/2024
1Radioisotopes (Radionuclides)IBA
01/2023
1Pentetic Acid (DTPA)FDA LinkGeneric
01/2021
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021
1human ERBB2 proteinIBA
01/2021
1111In-DTPA-trastuzumabIBA
01/2021
1Chelating AgentsIBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1gallium 68 PSMA-11IBA
02/2020
1Dihydrotachysterol (AT 10)IBA
06/2018

Therapy/Procedure

1Therapeutics
01/2023